Therapeutic Strategies in Heart Failure
Clinical Publishing, October 2007, Pages: 256
Therapeutic Strategies in Heart Failure is a pragmatic textbook written by active clinicians and investigators that is sharply focused on what the doctor needs to know to achieve the best possible outcome in patients with heart failure. The authors have incorporated all of the most recent definitive trial data, in a user friendly format, with frequent summary boxes and highlighted points of emphasis. The book begins with the prevention of heart failure, discusses best application of standard therapies, describes progress with current cutting edge treatments, and anticipates future therapeutic interventions. To complete the thought process, the final section deals with the avant garde issues in heart failure – the use of registry data, acute decompensated heart failure, device therapy, mechanical support for failing ventricles and a candid discussion of palliative care. The busy clinician is likely to find that Therapeutic Strategies in Heart Failure provides a useful template to optimize outcomes in the management of heart failure.
Benefits:
- Explores current, emerging and future therapies for heart failure
- Summaries of alternative management approaches included
- Evidence-based solutions provided by experts in the field
Readership:
- Specialists in cardiology and internal medicine
- General physicians
- Hospital pharmacists
Editors and Contributors
Preface
Section I: The prevention of heart failure
1. The treatment of hypertension as a strategy to prevent heart failure
S. D. Nesbitt
2. Insulin resistance: implications for the failing heart
B. Drabicki, S. Carr, R. P. Shannon
Section II: Established pharmacologic therapies for chronic heart failure
3. Digoxin therapy: does it still have a role in the management of heart failure?
J. Kalman
4. Neurohormonal activation in heart failure: ACE inhibitors
D. W. Markham
5. Neurohormonal activation in heart failure: angiotensin receptor antagonists
A. E. Atchley, G. Michael Felker
6. Neurohormonal activation in heart failure: _-blockers
S. A. Kamath, C. W. Yancy
7. Neurohormonal activation in heart failure: aldosterone antagonists
E. Hsich, R. C. Starling
Section III: Emerging pharmacologic therapies for heart failure
8. Nitric oxide biology and oxidative stress in heart failure: heart failure in African-Americans
C. W. Yancy
9. B-type natriuretic peptides in heart failure
J. Patel, J. Thomas Heywood
Section IV: Future pharmacologic therapies for heart failure
10. Arginine vasopressin antagonism in heart failure
J. Finley, O. Hedrich, M. A. Konstam, J. E. Udelson
11. Extracellular remodeling in heart failure – potential use of MMP inhibitors
D. S. Feldman, F. G. Spinale
12. Erythropoietin analogs in the treatment of anemia in heart failure
Y-D. Tang, S. D. Katz
Section V: Special topics in heart failure
13. Applying data from registries to improve outcomes in heart failure
G. C. Fonarow
14. Device therapy in heart failure
P. B. Adamson
15. Ventricular replacement therapy for heart failure
R. Bogaev
16. Palliative and hospice care in heart failure
P. J. Hauptman, P. Mikolajczak
Postscript
List of Abbreviations
Index
Edited by:
- CW Yancy, Medical Director, Baylor Heart and Vascular Institute, Baylor University Medical Center, Dallas, Texas, USA
- JB Young, Vice Chairman, Cardiovascular Medicine, The Cleveland Clinic, Cleveland, Ohio, USA
Product Samples
A sample for this product is available. Please Login/Register to download this sample.
Customers who bought this item also bought
All rights reserved. © Copyright 2013 Research and Markets WWW6
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network
